Dexcom (DXCM) Retained Earnings (2010 - 2026)

Dexcom (DXCM) has reported Retained Earnings for 17 consecutive years, with $2.9 billion the latest figure, recorded in Q2 2026.

• On a quarterly basis, Retained Earnings rose 53.1% year-over-year to $2.9 billion in Q2 2026; TTM through Jun 2026 was $2.9 billion, a 53.1% increase from a year earlier, with the FY2025 full-year figure at $2.4 billion, up 52.35% from the prior year.
• Retained Earnings was $2.9 billion for Q2 2026 at Dexcom, up from $2.6 billion in the prior quarter.
• Over five years, Retained Earnings peaked at $2.9 billion in Q2 2026 and troughed at $236.0 million in Q1 2022.
• A 5-year average of $1.3 billion and a median of $1.2 billion in 2024 frame the typical range for Retained Earnings.
• Across the five-year window, Retained Earnings surged 1486.07% in 2022 and jumped 43.58% in 2025, its largest moves.
• Over 5 years, Retained Earnings stood at $479.9 million in 2022, then surged by 112.84% to $1.0 billion in 2023, then jumped by 56.41% to $1.6 billion in 2024, then surged by 52.35% to $2.4 billion in 2025, then gained by 18.43% to $2.9 billion in 2026.
• The last three Retained Earnings figures came in at $2.9 billion (Q2 2026), $2.6 billion (Q1 2026), and $2.4 billion (Q4 2025), per Business Quant data.